EUVIMEDEUVIMED entdecken
Open Access

Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets

Fei Jiang, Yanlong Shi, Yue Wang, Chang Ge, Jun Zhu, Hanlu Fang, Yu Zhang, Yixiao Zhang, Haokun Jian, Tong Lei, Sheng Lan, Liyu Cao und 2 weitere

Aging · 2023

DOI: 10.18632/aging.204591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Fei Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansPrognosisBiomarkersImmunotherapyCell Cycle ProteinsMicrosatellite InstabilityRNA, MessengerTumor MicroenvironmentShc Signaling Adaptor Proteins

Stichwörter der Autor:innen

SHCBP1biomarkerimmune microenvironmentpan-cancerprognosis

Substanzen

BiomarkersCell Cycle ProteinsRNA, MessengerSHCBP1 protein, humanShc Signaling Adaptor Proteins

Autor:innen und Institutionen

  • Department of General Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China.
  • Hepatopancreatobiliary Center, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Pathology, Anhui Medical University, Hefei, Anhui, China.
  • Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, China.
  • School of Basic Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
  • The Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.

Zitieren

APA

Jiang, F., Shi, Y., Wang, Y., Ge, C., Zhu, J., Fang, H., Zhang, Y., Zhang, Y., Jian, H., Lei, T., Lan, S., Cao, L., Yu, H., & Fang, D. (2023). Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets. Aging. https://doi.org/10.18632/aging.204591

Vancouver

Jiang F, Shi Y, Wang Y, Ge C, Zhu J, Fang H, et al. Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets. Aging. 2023. doi:10.18632/aging.204591

BibTeX
@article{Jiang2023,
  author = {Jiang, Fei and Shi, Yanlong and Wang, Yue and Ge, Chang and Zhu, Jun and Fang, Hanlu and Zhang, Yu and Zhang, Yixiao and Jian, Haokun and Lei, Tong and Lan, Sheng and Cao, Liyu and Yu, Hongzhu and Fang, Debao},
  title = {Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204591}
}
Kostenlos starten →